Home/ Supplements/ Alpha Lipoic Acid/ Nutrient Driver

Nutrient Driver

product on market Capsule MTS Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like berberine, banaba leaf, and alpha lipoic acid, which have moderate to strong evidence for supporting glucose metabolism and insulin sensitivity. Gymnema sylvestre and Chromax further assist in managing blood sugar levels. Overall, the evidence coverage for this specific blend is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Nutrient Driver
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Chromax
200 mcg (167% DV)
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Banaba Leaf Extract
100 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Gymnema Leaf Extract
100 mg

Other Ingredients

Cellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: As a dietary supplement- Training days: Consume 1 serving with your post-workout carb-containing shake or meal, and 1 serving with any other high-carb meal of the day. Non-Training Days: Consume 1 serving with each of 2 high-carb meals.

Warnings & Precautions

Warning: Read entire label prior to use. Discontinue use and call a physician or licensed qualified health care professional immediately if adverse reactions occur. Do not exceed recommended serving.

Not for use by individuals under the age of 18. Keep out of reach of children.

Do not use if you are pregnant or nursing. Consult your physician prior to use if you are using any medications and/or have any medical conditions.

Formulation Notes

MTS Nutrition Nutrient Driver is the ultimate glucose disposal agent. It works to help Drive nutrients into your muscles, prevent fat storage, and prevent negative health issues caused by fluctuations in blood sugar. If that wasn't enough, check out all the other health benefits of taking Nutrient Driver! Supports glucose metabolism Helps regulate insulin release Decreased food cravings Potent water and fat-soluble antioxidant Increased system support Brain health support

FDA Inspected Facility Made in a GMP Facility 100% Satisfaction Guarantee Glucose disposal agent 25% Hunger reduction 26% Decrease in fasting insulin

50mg r-ALA

Metadata

Product Details

UPC / SKU8 55590 00638 9
DSLD Entry Date2025-02-23
Product TypeOther Combinations
FormCapsule
DSLD ID323116
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.